Share this Article
How CH, Fock KM
Correspondence: Prof Fock Kwong Ming, Kwong.Ming.Fock@easternhealth.sg
SUMMARY
Singapore’s rapidly evolving economy and social progress has helped accelerate the milestones of healthcare development in the country.(1) In 1970, a committee on specialisation was commissioned by the Singapore government to look into the development of specialised medical services and postgraduate specialty training. Since then, there has been a steady focus on the development of our healthcare sector and the advancement of medical specialties. This has catapulted Singapore’s health system to a level on par with other advanced nations.(2)
Today, healthcare systems around the world spend trillions of dollars annually to tackle the growing challenges in healthcare.(2-6) These challenges include epidemiological transitions of death rates (from maternal, perinatal and infectious diseases to cardiovascular diseases and cancers) and an ageing population with improved life expectancies.(2,7) Current lifestyle trends, which are by and large the result of technological advancements, have led to individuals having an increased number of risk factors, leading to the increased prevalence of multiple chronic diseases.(2,6) These chronic diseases are also increasingly being diagnosed in the younger adult population in the recent years.(2,4-6,8) Such trends will result in greater financial costs for the nation and the individual, and our current healthcare system may not remain sustainable if we continue to invest in and develop what had served us well in the past five decades.(1)
Singapore Med J 2014; 55(3): 126-127; http://dx.doi.org/10.11622/smedj.2014027
REFERENCES
| 1. Lee HS. Opening Address. World Health Summit Regional Meeting, April 8, 2013, Singapore. | ||||
| 2. OECD iLibrary. Health at a Glance 2013: OECD Indicators [online]. Available at: http://dx.doi.org/10.1787/health_glance-2013-en. Accessed February 28, 2014. http://dx.doi.org/10.1787/health_glance-2013-en | ||||
| 3. Roehrig CS, Rousseau DM. The growth in cost per case explains far more of US health spending increases than rising disease prevalence. Health Aff (Millwood) 2011; 30:1657-63. http://dx.doi.org/10.1377/hlthaff.2010.0644 | ||||
| 4. Gaziano T. Cardiovascular disease in the developing world and its costeffective management. Circulation 2005; 112:3547-53. http://dx.doi.org/10.1161/CIRCULATIONAHA.105.591792 | ||||
| 5. Gaziano TA, Bitton A, Anand S, Abrahams-Gessel S, Murphy A. Growing epidemic of coronary heart disease in low and middle income countries. Curr Probl Cardiol 2010; 35:72-115. http://dx.doi.org/10.1016/j.cpcardiol.2009.10.002 | ||||
| 6. Süssmuth-Dyckerhoff C, Wang J. China's health care reforms. Health International 2010; 10:54-67. | ||||
| 7. Alliance for Aging Research. The Silver Book: Chronic Disease and Medical Innovation in an Aging Nation, 2006. | ||||
| 8. Engberding N, Wenger NK. Cardiovascular disease prevention tailored for women. Expert Rev Cardiovasc Ther 2008; 6:1123-34. http://dx.doi.org/10.1586/14779072.6.8.1123 | ||||
| 9. Henke N, Kelsey T, Whately H. Transparency: the most powerful driver of health care improvement? Health International 2011; 11:64-73. | ||||
| 10. Jamison DT, Breman JG, Measham AR, et al, eds. Priorities in Health. Disease Control Priorities Project. Washington (DC): World Bank, 2006. | ||||
| 11. Briggs CJ, Garner P. Strategies for integrating primary health services in middle and low-income countries at the point of delivery. Cochrane Database Syst Rev 2006; 19:CD003318. | ||||
| 12. World Health Organization. Everybody's Business: Strengthening Health Systems to Improve Health Outcomes. WHO's Framework for Action. Geneva: WHO, 2007. | ||||
| 13. World Health Organization. The World Health Report 2008: Primary health care (now more than ever). Geneva: WHO, 2008. | ||||